Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Neurology|September 18, 2010
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]Alex Iranzo, Francisco Lomeña, Heike Stockner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2010
Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderlyDaniela Berg, Klaus Seppi, Inga Liepelt, et al.
Journal of Neurology|November 6, 2013
Risk factors and prodromal markers and the development of Parkinson's diseaseStefanie Lerche, Klaus Seppi, Stefanie Behnke, et al.
Sleep|March 15, 2021
Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson's diseaseJirada Sringean, Ambra Stefani, Kathrin Marini, et al.
Annals of Neurology|August 7, 2020
Non-Motor Symptoms in Parkinson's Disease are Reduced by NabiloneMarina Peball, Florian Krismer, Hans-Günther Knaus, et al.
Journal of Neurology|December 31, 2020
Characterization of gait variability in multiple system atrophy and Parkinson's diseaseVictoria Sidoroff, Cecilia Raccagni, Christine Kaindlstorfer, et al.
Gerontology|September 11, 2018
Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional StudyMarina Peball, Philipp Mahlknecht, Mario Werkmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Stefanie Behnke, Klaus Seppi, et al.
Archives of Neurology|July 13, 2011
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsDaniela Berg, Klaus Seppi, Stefanie Behnke, et al.
Movement Disorders Clinical Practice|November 19, 2024
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based StudyPhilipp Mahlknecht, Simon Leiter, Corinne Horlings, et al.
Pageof 4